Rani Therapeutics Holdings Inc

Change company Symbol lookup

Select an option...

RANI Rani Therapeutics Holdings Inc

RONI Rice Acquisition Corp II

SUP Superior Industries International Inc

NECB Northeast Community Bancorp Inc

NIDB Northeast Indiana Bancorp Inc

SPXC SPX Technologies Inc

ULTA Ulta Beauty Inc

HTGM HTG Molecular Diagnostics Inc

MLEC Moolec Science SA

GDHG Golden Heaven Group Holdings Ltd

Go

Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company. The Company is focused on advancing technologies to enable the administration of biologics and drugs orally, to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The Company has developed a drug-agnostic oral delivery platform, the RaniPill capsule, which is designed to deliver a variety of drug substances, including large molecules, such as peptides, proteins, and antibodies. The RaniPill capsule, the RaniPill GO, is designed to deliver up to a three micrograms (mg) dose of drug with high bioavailability. The capsule includes a coating designed to withstand stomach acid but dissolve in the jejunum portion of the small intestine. Its pipeline includes RT-101, RT-102, RT-105, RT-110 and RT-111. Its RT-101 is an Octreotide for the treatment of NETs and acromegaly. It manufactures and assembles RaniPill capsules at its facility in San Jose, California.